Singapore markets open in 2 hours 5 minutes

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.54000.0000 (0.00%)
At close: 03:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 33.03M
Enterprise value 76.46M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.47
Price/book (mrq)1.43
Enterprise value/revenue 1.03
Enterprise value/EBITDA 21.71

Trading information

Stock price history

Beta (5Y monthly) 1.07
52-week change 3-74.02%
S&P500 52-week change 3-9.13%
52-week high 36.7900
52-week low 31.4300
50-day moving average 31.9738
200-day moving average 32.2986

Share statistics

Avg vol (3-month) 34.54k
Avg vol (10-day) 33.83k
Shares outstanding 519.94M
Implied shares outstanding 6N/A
Float 816.58M
% held by insiders 110.01%
% held by institutions 16.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Dec 2018
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin -10.91%
Operating margin (ttm)-20.60%

Management effectiveness

Return on assets (ttm)-6.90%
Return on equity (ttm)-58.88%

Income statement

Revenue (ttm)74.08M
Revenue per share (ttm)3.92
Quarterly revenue growth (yoy)-12.30%
Gross profit (ttm)47.48M
Net income avi to common (ttm)-8.08M
Diluted EPS (ttm)-0.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.57M
Total cash per share (mrq)0.48
Total debt (mrq)53M
Total debt/equity (mrq)229.01
Current ratio (mrq)1.00
Book value per share (mrq)1.16

Cash flow statement

Operating cash flow (ttm)-759k
Levered free cash flow (ttm)-16.26M